drugset
drugset / Trial / NCT06486662

A Clinical Study Investigating OM-85-IN Safety and Tolerability in Healthy Volunteers and Mild Allergic Asthma Patients

NCT06486662 ↗

Phase 1 Completed 41 enrolled OM Pharma SA
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will assess the safety and tolerability of OM-85-IN compared to placebo in healthy volunteers and mild asthmatic patients

Timeline

Start
2024-06-14
Primary completion
2025-02-19
Completion
2025-02-19

Drugs

EvaluationDrugModalityDoseRoute
Subject OM-85-IN Unknown — —

Indications

allergic asthma